SCOPUS 정보 검색 플랫폼

Volumn 112, Issue 4, 2013, Pages 472-478

Comparison of the efficacy and safety of two rivaroxaban doses in acute coronary syndrome (from ATLAS ACS 2-TIMI 51)

(8) Mega, Jessica L a Braunwald, Eugene a Wiviott, Stephen D a Murphy, Sabina A a Plotnikov, Alexei b Gotcheva, Nina c Ruda, Mikhail d Gibson, C Michael a,e

a BRIGHAM AND WOMEN S HOSPITAL (United States)

b JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT (United States)

c NATIONAL HEART HOSPITAL (Bulgaria)

d INSTITUTE OF EXPERIMENTAL CARDIOLOGY (Russian Federation)

e HARVARD MEDICAL SCHOOL (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; RIVAROXABAN;

ACUTE CORONARY SYNDROME; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG EFFICACY; DRUG SAFETY; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STENT THROMBOSIS;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANTICOAGULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDPOINT DETERMINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MORPHOLINES; THIOPHENES; TREATMENT OUTCOME;

EID: 84881190857 PISSN: 00029149 EISSN: 18791913 Source Type: Journal
DOI: 10.1016/j.amjcard.2013.04.011 Document Type: Article

Times cited : (40)

References (11)

1
- 80052592404
- Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
- M.R. Patel, K.W. Mahaffey, J. Garg, G. Pan, D.E. Singer, W. Hacke, G. Breithardt, J.L. Halperin, G.J. Hankey, J.P. Piccini, R.C. Becker, C.C. Nessel, J.F. Paolini, S.D. Berkowitz, K.A. Fox, and R.M. Califf Rivaroxaban versus warfarin in nonvalvular atrial fibrillation N Engl J Med 365 2011 883 891
- (2011) N Engl J Med , vol.365 , pp. 883-891
- Patel, M.R.¹ Mahaffey, K.W.² Garg, J.³ Pan, G.⁴ Singer, D.E.⁵ Hacke, W.⁶ Breithardt, G.⁷ Halperin, J.L.⁸ Hankey, G.J.⁹ Piccini, J.P.¹⁰ Becker, R.C.¹¹ Nessel, C.C.¹² Paolini, J.F.¹³ Berkowitz, S.D.¹⁴ Fox, K.A.¹⁵ Califf, R.M.¹⁶

2
- 84859385808
- Oral rivaroxaban for the treatment of symptomatic pulmonary embolism
- EINSTEIN-PE Investigators, H.R. Büller, M.H. Prins, A.W. Lensin, H. Decousus, B.F. Jacobson, E. Minar, J. Chlumsky, P. Verhamme, P. Wells, G. Agnelli, A. Cohen, S.D. Berkowitz, H. Bounameaux, B.L. Davidson, F. Misselwitz, A.S. Gallus, G.E. Raskob, S. Schellong, and A. Segers Oral rivaroxaban for the treatment of symptomatic pulmonary embolism N Engl J Med 366 2012 1287 1297
- (2012) N Engl J Med , vol.366 , pp. 1287-1297
- Büller, H.R.¹ Prins, M.H.² Lensin, A.W.³ Decousus, H.⁴ Jacobson, B.F.⁵ Minar, E.⁶ Chlumsky, J.⁷ Verhamme, P.⁸ Wells, P.⁹ Agnelli, G.¹⁰ Cohen, A.¹¹ Berkowitz, S.D.¹² Bounameaux, H.¹³ Davidson, B.L.¹⁴ Misselwitz, F.¹⁵ Gallus, A.S.¹⁶ Raskob, G.E.¹⁷ Schellong, S.¹⁸ Segers, A.¹⁹

3
- 78650619315
- Oral rivaroxaban for symptomatic venous thromboembolism
- R. Bauersachs, S.D. Berkowitz, B. Brenner, H.R. Buller, H. Decousus, A.S. Gallus, A.W. Lensing, F. Misselwitz, M.H. Prins, G.E. Raskob, A. Segers, P. Verhamme, P. Wells, G. Agnelli, H. Bounameaux, A. Cohen, B.L. Davidson, F. Piovella, and S. Schellong Oral rivaroxaban for symptomatic venous thromboembolism N Engl J Med 363 2010 2499 2510
- (2010) N Engl J Med , vol.363 , pp. 2499-2510
- Bauersachs, R.¹ Berkowitz, S.D.² Brenner, B.³ Buller, H.R.⁴ Decousus, H.⁵ Gallus, A.S.⁶ Lensing, A.W.⁷ Misselwitz, F.⁸ Prins, M.H.⁹ Raskob, G.E.¹⁰ Segers, A.¹¹ Verhamme, P.¹² Wells, P.¹³ Agnelli, G.¹⁴ Bounameaux, H.¹⁵ Cohen, A.¹⁶ Davidson, B.L.¹⁷ Piovella, F.¹⁸ Schellong, S.¹⁹

4
- 65549169515
- Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): A randomised trial
- A.G. Turpie, M.R. Lassen, B.L. Davidson, K.A. Bauer, M. Gent, L.M. Kwong, F.D. Cushner, P.A. Lotke, S.D. Berkowitz, T.J. Bandel, A. Benson, F. Misselwitz, and W.D. Fisher Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial Lancet 373 2009 1673 1680
- (2009) Lancet , vol.373 , pp. 1673-1680
- Turpie, A.G.¹ Lassen, M.R.² Davidson, B.L.³ Bauer, K.A.⁴ Gent, M.⁵ Kwong, L.M.⁶ Cushner, F.D.⁷ Lotke, P.A.⁸ Berkowitz, S.D.⁹ Bandel, T.J.¹⁰ Benson, A.¹¹ Misselwitz, F.¹² Fisher, W.D.¹³

5
- 67649562905
- Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): A randomised, double-blind, phase II trial
- J.L. Mega, E. Braunwald, S. Mohanavelu, P. Burton, R. Poulter, F. Misselwitz, V. Hricak, E.S. Barnathan, P. Bordes, A. Witkowski, V. Markov, L. Oppenheimer, and C.M. Gibson Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial Lancet 374 2009 29 38
- (2009) Lancet , vol.374 , pp. 29-38
- Mega, J.L.¹ Braunwald, E.² Mohanavelu, S.³ Burton, P.⁴ Poulter, R.⁵ Misselwitz, F.⁶ Hricak, V.⁷ Barnathan, E.S.⁸ Bordes, P.⁹ Witkowski, A.¹⁰ Markov, V.¹¹ Oppenheimer, L.¹² Gibson, C.M.¹³

6
- 84862907587
- Rivaroxaban in patients with a recent acute coronary syndrome
- J.L. Mega, E. Braunwald, S.D. Wiviott, J.P. Bassand, D.L. Bhatt, C. Bode, P. Burton, M. Cohen, N. Cook-Bruns, K.A. Fox, S. Goto, S.A. Murphy, A.N. Plotnikov, D. Schneider, X. Sun, F.W. Verheugt, and C.M. Gibson Rivaroxaban in patients with a recent acute coronary syndrome N Engl J Med 366 2012 9 19
- (2012) N Engl J Med , vol.366 , pp. 9-19
- Mega, J.L.¹ Braunwald, E.² Wiviott, S.D.³ Bassand, J.P.⁴ Bhatt, D.L.⁵ Bode, C.⁶ Burton, P.⁷ Cohen, M.⁸ Cook-Bruns, N.⁹ Fox, K.A.¹⁰ Goto, S.¹¹ Murphy, S.A.¹² Plotnikov, A.N.¹³ Schneider, D.¹⁴ Sun, X.¹⁵ Verheugt, F.W.¹⁶ Gibson, C.M.¹⁷

7
- 79955887785
- Rationale and design of the Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects with Acute Coronary Syndrome-Thrombolysis in Myocardial Infarction 51 (ATLAS-ACS 2 TIMI 51) trial: A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of rivaroxaban in subjects with acute coronary syndrome
- C.M. Gibson, J.L. Mega, P. Burton, S. Goto, F. Verheugt, C. Bode, A. Plotnikov, X. Sun, N. Cook-Bruns, and E. Braunwald Rationale and design of the Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects With Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction 51 (ATLAS-ACS 2 TIMI 51) trial: a randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of rivaroxaban in subjects with acute coronary syndrome Am Heart J 161 2011 815 821
- (2011) Am Heart J , vol.161 , pp. 815-821
- Gibson, C.M.¹ Mega, J.L.² Burton, P.³ Goto, S.⁴ Verheugt, F.⁵ Bode, C.⁶ Plotnikov, A.⁷ Sun, X.⁸ Cook-Bruns, N.⁹ Braunwald, E.¹⁰

8
- 42149119040
- Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: A subanalysis of a randomised trial
- S.D. Wiviott, E. Braunwald, C.H. McCabe, I. Horvath, M. Keltai, J.P. Herrman, F. Van de Werf, W.E. Downey, B.M. Scirica, S.A. Murphy, and E.M. Antman Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial Lancet 371 2008 1353 1363
- (2008) Lancet , vol.371 , pp. 1353-1363
- Wiviott, S.D.¹ Braunwald, E.² McCabe, C.H.³ Horvath, I.⁴ Keltai, M.⁵ Herrman, J.P.⁶ Van De Werf, F.⁷ Downey, W.E.⁸ Scirica, B.M.⁹ Murphy, S.A.¹⁰ Antman, E.M.¹¹

9
- 57449102051
- Antiplatelet therapy use after discharge among acute myocardial infarction patients with in-hospital bleeding
- T.Y. Wang, L. Xiao, K.P. Alexander, S.V. Rao, M.N. Kosiborod, J.S. Rumsfeld, J.A. Spertus, and E.D. Peterson Antiplatelet therapy use after discharge among acute myocardial infarction patients with in-hospital bleeding Circulation 118 2008 2139 2145
- (2008) Circulation , vol.118 , pp. 2139-2145
- Wang, T.Y.¹ Xiao, L.² Alexander, K.P.³ Rao, S.V.⁴ Kosiborod, M.N.⁵ Rumsfeld, J.S.⁶ Spertus, J.A.⁷ Peterson, E.D.⁸

10
- 78650223707
- Patterns of discharge antiplatelet therapy and late outcomes among 8,582 patients with bleeding during acute coronary syndrome: A pooled analysis from PURSUIT, PARAGON-A, PARAGON-B, and SYNERGY
- M.Y. Chan, J.L. Sun, T.Y. Wang, R.D. Lopes, M.E. Jolicoeur, K.S. Pieper, S.V. Rao, L.K. Newby, K.W. Mahaffey, R.A. Harrington, and E.D. Peterson Patterns of discharge antiplatelet therapy and late outcomes among 8,582 patients with bleeding during acute coronary syndrome: a pooled analysis from PURSUIT, PARAGON-A, PARAGON-B, and SYNERGY Am Heart J 160 2010 1056 1064
- (2010) Am Heart J , vol.160 , pp. 1056-1064
- Chan, M.Y.¹ Sun, J.L.² Wang, T.Y.³ Lopes, R.D.⁴ Jolicoeur, M.E.⁵ Pieper, K.S.⁶ Rao, S.V.⁷ Newby, L.K.⁸ Mahaffey, K.W.⁹ Harrington, R.A.¹⁰ Peterson, E.D.¹¹

11
- 80052162121
- Apixaban with antiplatelet therapy after acute coronary syndrome
- J.H. Alexander, R.D. Lopes, S. James, R. Kilaru, Y. He, P. Mohan, D.L. Bhatt, S. Goodman, F.W. Verheugt, M. Flather, K. Huber, D. Liaw, S.E. Husted, J. Lopez-Sendon, R. De Caterina, P. Jansky, H. Darius, D. Vinereanu, J.H. Cornel, F. Cools, D. Atar, J.L. Leiva-Pons, M. Keltai, H. Ogawa, P. Pais, A. Parkhomenko, W. Ruzyllo, R. Diaz, H. White, M. Ruda, M. Geraldes, J. Lawrence, R.A. Harrington, and L. Wallentin Apixaban with antiplatelet therapy after acute coronary syndrome N Engl J Med 365 2011 699 708
- (2011) N Engl J Med , vol.365 , pp. 699-708
- Alexander, J.H.¹ Lopes, R.D.² James, S.³ Kilaru, R.⁴ He, Y.⁵ Mohan, P.⁶ Bhatt, D.L.⁷ Goodman, S.⁸ Verheugt, F.W.⁹ Flather, M.¹⁰ Huber, K.¹¹ Liaw, D.¹² Husted, S.E.¹³ Lopez-Sendon, J.¹⁴ De Caterina, R.¹⁵ Jansky, P.¹⁶ Darius, H.¹⁷ Vinereanu, D.¹⁸ Cornel, J.H.¹⁹ Cools, F.²⁰ more..

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.